Shares of Nuwellis, Inc. (NASDAQ:NUWE – Free Report) are set to reverse split before the market opens on Friday, June 28th. The 1-35 reverse split was announced on Friday, June 28th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, June 28th.
Nuwellis Stock Performance
NASDAQ NUWE traded down $0.07 during trading hours on Wednesday, reaching $0.14. The stock had a trading volume of 11,182,318 shares, compared to its average volume of 3,782,285. The stock has a fifty day moving average of $0.23 and a 200 day moving average of $0.40. The stock has a market cap of $2.58 million, a P/E ratio of -0.02 and a beta of 0.49. Nuwellis has a 52-week low of $0.12 and a 52-week high of $2.85.
Nuwellis (NASDAQ:NUWE – Get Free Report) last issued its earnings results on Tuesday, May 7th. The company reported ($0.60) EPS for the quarter. The firm had revenue of $1.86 million during the quarter. Nuwellis had a negative net margin of 202.97% and a negative return on equity of 316.90%.
Nuwellis Company Profile
Nuwellis, Inc, a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.
Read More
- Five stocks we like better than Nuwellis
- Which Wall Street Analysts are the Most Accurate?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Pros And Cons Of Monthly Dividend Stocks
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- What is a buyback in stocks? A comprehensive guide for investors
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.
